Consolidated net sales for the fiscal year ending December 2025 amounted to 6,539,159 thousand yen (10.7% YoY increase), operating income was 349,464 thousand yen, and net income attributable to owners of parent was 280,242 thousand yen. Earnings guidance for the fiscal year ending December 2026 is not provided due to delisting planned following a tender offer.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3902","jir_company_name":"Medical Data Vision Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-02-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/3902-20260209-02.pdf","jir_short_summary":"Consolidated net sales for the fiscal year ending December 2025 amounted to 6,539,159 thousand yen (10.7% YoY increase), operating income was 349,464 thousand yen, and net income attributable to owners of parent was 280,242 thousand yen. Earnings guidance for the fiscal year ending December 2026 is not provided due to delisting planned following a tender offer.","jir_summary":"### Business Overview\nThe consolidated results for the fiscal year ending December 2025 showed net sales of 6,539,159 thousand yen (10.7% YoY increase), operating income of 349,464 thousand yen (a significant increase from operating income of 3,765 thousand yen in the previous period), ordinary income of 360,721 thousand yen, and net income attributable to owners of parent of 280,242 thousand yen (recovered from a net loss of 791,169 thousand yen in the previous period). Net sales increased across all service segments including Data Network Services, Data Utilization Services, and Other Services. In particular, Data Utilization Services achieved record-high sales due to an increase in sales personnel. The patient count in the large-scale medical database expanded to 55.02 million, an increase of 4.73 million compared to the same month the previous year.\n\n### Financial Position and Cash Flows\nTotal assets slightly increased to 4,778,436 thousand yen compared to the previous period, while net assets slightly decreased to 3,111,239 thousand yen. The equity ratio remained stable at 64.4%. Cash flow from operating activities was positive at 782,205 thousand yen, resulting in an increase in cash and cash equivalents at the end of the period to 1,713,216 thousand yen. Cash outflows from investing activities amounted to 96,927 thousand yen, financing activities outflows were 319,328 thousand yen, and dividend payments totaled 245,897 thousand yen.\n\n### Outlook\nDue to the tender offer disclosed by Nihon Life Insurance Company on December 15, 2025, the Company\u2019s shares are scheduled to be delisted, and consolidated earnings forecasts for the fiscal year ending December 2026 are not provided. The tender offer has been successful, and the tender offeror is expected to become the largest shareholder. Accordingly, the Company intends to undergo necessary procedures for delisting.","jir_financial_highlights":"Net Sales: 6,539,159 thousand yen (10.7% YoY increase)\nOperating Income: 349,464 thousand yen (previous period had 3,765 thousand yen (significant increase))\nNet Income Attributable to Owners of Parent: 280,242 thousand yen (turned profitable from a net loss of 791,169 thousand yen in the previous period)\nEquity Ratio: 64.4% (slight decrease from 65.1% in the previous period)\nCash and Cash Equivalents at End of Period: 1,713,216 thousand yen (increase from 1,347,266 thousand yen in the previous period)\nNumber of Issued Shares (Common Stock): 40,027,526 shares (unchanged from previous period)\nDividend (Year-end): 0.00 yen (changed to no dividend from 6.50 yen in the previous period)","jir_category":"","jir_hashtags":"#MedicalDataVisionCoLtd, #FinancialSummary, #financial_summary, #JapaneseStocks","jir_key_figures":"Net Sales: 6,539,159 thousand yen (10.7% YoY increase)\nOperating Income: 349,464 thousand yen (significant increase from 3,765 thousand yen in previous period)\nNet Income Attributable to Owners of Parent: 280,242 thousand yen (turning profitable from a net loss of 791,169 thousand yen in previous period)","jir_meta_title":"Medical Data Vision Financial Summary for FY December 2025 Sales of 6.54 Billion Yen Up 10.7%","jir_meta_description":"Financial summary for Medical Data Vision Co., Ltd. for the fiscal year ending December 2025. Net sales of 6,539,159 thousand yen (10.7% YoY increase), operating income of 349,464 thousand yen, and net income of 280,242 thousand yen. Scheduled for delisting following a tender offer.","jir_og_title":"Medical Data Vision Announces Financial Summary for Fiscal Year Ending December 2025","jir_og_description":"For the fiscal year ending December 2025, net sales were 6.54 billion yen, operating income was 349 million yen, and net income was 280 million yen. Delisting is scheduled following a tender offer.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Sales Trend (thousand yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending Dec 2024\\\",\\\"Fiscal Year Ending Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[5906958,6539159],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trend (thousand yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending Dec 2024\\\",\\\"Fiscal Year Ending Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[3765,349464],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (thousand yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending Dec 2024\\\",\\\"Fiscal Year Ending Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[-791169,280242],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":false}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Revenue Breakdown by Service Segment (Fiscal Year Ending December 2025)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Data Network Services\\\",\\\"Data Utilization Services\\\",\\\"Other Services\\\"],\\\"datasets\\\":[{\\\"data\\\":[1353600,4621597,563960],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\",\\\"#e15759\\\"]}]}}\"}, {\"jir_chart_id\": \"cash_flow_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Cash Flow Status (thousand yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Operating Activities\\\",\\\"Investing Activities\\\",\\\"Financing Activities\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Fiscal Year Ending Dec 2024\\\",\\\"data\\\":[-877849,-592972,-399985],\\\"backgroundColor\\\":\\\"#4e79a7\\\"},{\\\"label\\\":\\\"Fiscal Year Ending Dec 2025\\\",\\\"data\\\":[782205,-96927,-319328],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":false}}}}\"}]","ir_related_company":17052,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-26028","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n